📰 Mc Services News
Page 3 - Mc Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mc Services. Real-time updates on events, politics, business and more.
March 13, 2024
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to...
March 12, 2024
Issuer: Mainz Biomed N.V. / Key word(s): Miscellaneous Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading t...
February 27, 2024
BERKELEY, Calif. and MAINZ, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, is proud to announce its participation as an exhibitor at the esteemed Gynecology Congress (‘Gynäkologie und Geburtshilfe aktuell’) in Stuttgart, Germany, on March 1st. This engagement signifies the company's commitment to advanci...
February 21, 2024
Issuer: Mainz BioMed N.V. / Key word: Miscellaneous Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy 21.02.2024...
February 19, 2024
CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty Clermont-Ferrand, France, 19...
February 16, 2024
Detailed price information for Mainz Biomed N.V. (MYNZ-Q) from The Globe and Mail including charting and trades.
February 13, 2024
MUNICH, GERMANY / ACCESSWIRE / February 13, 2024 / The eighteenth annual BIO-Europe Spring ® , the premier springtime partnering conference, will take place March 18-20, 2024 in Barcelona, Spain . After remarkable attendance in Basel last year, the ...
February 6, 2024
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous06.02.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY Company opens own physician-led laboratory...
January 25, 2024
InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible...
January 11, 2024
Issuer: Mainz BioMed N.V. / Key word(s): Conference11.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology SymposiumBERKELEY, US – MAINZ, Germany – January 11, 2024 — Mainz Biomed N.V. (NASDAQ:M...